Thông tin thuốc gốc
Chỉ định và Liều dùng
Mild dementia in Alzheimer's disease, Moderate dementia in Alzheimer's disease, Severe dementia in Alzheimer's disease
Adult: Initially, 5 mg once daily at bedtime, may increase after 1 mth to 10 mg once daily, if necessary. Max: 10 mg daily.
Elderly: Initially, 5 mg daily at bedtime, increase if necessary up to 10 mg once daily at bedtime after 4-6 wk.
Cách dùng
May be taken with or without food. Take in the evening just prior to retiring. 23-mg tab: Swallow whole, do not split/crush/chew. ODT: Allow to dissolve on the tongue & follow w/ water.
Thận trọng
Patient w/ history of asthma or COPD, sick sinus syndrome, supraventricular conduction abnormalities, susceptibility to peptic ulcer, seizures, GI or urinary tract obstruction. Hepatic impairment. Pregnancy and lactation.
Tác dụng không mong muốn
Diarrhoea, muscle cramps, fatigue, nausea, vomiting, headache, insomnia, abnormal dreams, common cold, aggression, agitation, anorexia, dizziness, hallucinations, pruritus, rash, syncope, urinary incontinence, bradycardia, duodenal/gastric ulcers, GI haemorrhage, seizures. Rarely, AV block, extrapyramidal symptoms, hepatitis, bladder outflow obstruction, sino-atrial block.
Potentially Fatal: Rarely, neuroleptic malignant syndrome.
Thông tin tư vấn bệnh nhân
May impair ability to drive or operate machinery.
Chỉ số theo dõi
Monitor mental status, wt, pulse, symptoms of GI intolerance or bleeding.
Quá liều
Symptoms: Cholinergic crisis characterised by severe nausea, vomiting, salivations, sweating, bradycardia, hypotension, resp depression, collapse, convulsion, muscle weakness. Management: Supportive treatment and use of anticholinergic such as IV atropine.
Tương tác
Increased risk of neuroleptic malignant syndrome w/ antipsychotics. Synergistic effect w/ succinylcholine, similar neuromuscular blocking agents, or cholinergic agonists (e.g. bethanechol). May interfere w/ the activity of anticholinergic medications. Increased plasma concentration when used w/ CYP3A4 inhibitors (e.g. ketoconazole, erythromycin) and CYP 2D6 inhibitors (e.g. fluoxetine, quinidine). Decreased plasma concentrations w/ enzyme inducers (e.g. rifampicin, phenytoin).
Tác dụng
Description: Donepezil reversibly and noncompetitively inhibits centrally-active acetylcholinesterase that is responsible for the hydrolysis of acetylcholine, resulting to increased concentration of acetylcholine in the CNS.
Absorption: Well absorbed from the GI tract. Time to peak plasma concentration: 3-4 hr.
Distribution: Volume of distribution: 12-16 L/kg. Protein binding: Approx 96% (to albumin (75%) and α1-acid glycoprotein (21%).
Metabolism: Extensively metabolised in the liver, mainly by CYP3A4 isoenzyme and to a lesser extent by CYP2D6, into 4 major metabolites.
Excretion: Via urine (57%, as unchanged drug and metabolites) and faeces (15%). Elimination half-life: Approx 70 hr.
Đặc tính

Chemical Structure Image

Source: National Center for Biotechnology Information. PubChem Database. Donepezil, CID=3152, (accessed on Jan. 21, 2020)

Bảo quản
Store between 15-30°C.
Phân loại MIMS
Thuốc trị bệnh thoái hóa thần kinh
Phân loại ATC
N06DA02 - donepezil ; Belongs to the class of anticholinesterases. Used in the management of dementia.
Tài liệu tham khảo
Anon. Donepezil. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. Accessed 09/11/2016.

Aricept Solution (Eisai Inc). DailyMed. Source: U.S. National Library of Medicine. Accessed 09/11/2016.

Buckingham R (ed). Donepezil Hydrochloride. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. . Accessed 09/11/2016.

Donepezil Hydrochloride 5 mg and 10 mg Tablet, Film Coated (Major Pharmaceuticals). DailyMed. Source: U.S. National Library of Medicine. Accessed 09/11/2016.

Donepezil Hydrochloride Tablet, Film Coated (Camber Pharmaceuticals, Inc). DailyMed. Source: U.S. National Library of Medicine. Accessed 09/11/2016.

Joint Formulary Committee. Donepezil hydrochloride. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. Accessed 09/11/2016.

McEvoy GK, Snow EK, Miller J et al (eds). Donepezil Hydrochloride. AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). Accessed 09/11/2016.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Donepezil từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2023 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi
  • Alzepil
  • Anepzil
  • Apezil
  • Torpezil
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in